Kazuhiro Asada
Kita, 4208527, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Composition and structure of stratum corneum intercellular lipids in patients with osimertinib-induced hand-foot syndrome.
Journal: Cancer chemotherapy and pharmacology
Published: March 18, 2026
Diffuse Large B-Cell Lymphoma With Pulmonary and Gastric Involvement Mimicking Nontuberculous Mycobacterial Lung Disease.
Journal: Respirology case reports
Published: February 20, 2026
Geriatric nutritional risk index in antifibrotic therapy can predict tolerability and mortality risk.
Journal: Scientific reports
Published: January 14, 2026
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies.
Journal: JTO clinical and research reports
Published: March 07, 2025
Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials.
Journal: BMC cancer
Published: February 14, 2025
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study.
Journal: Therapeutic advances in medical oncology
Published: October 16, 2024
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study.
Journal: Therapeutic advances in medical oncology
Published: July 10, 2024
Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 04, 2024
Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II study.
Journal: BMC pulmonary medicine
Published: March 16, 2024
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II study.
Journal: Journal for immunotherapy of cancer
Published: July 10, 2023
Last Updated: 09/26/2026